Sanofi-GSK launch final phase of Covid vaccine trials

French pharmaceutical giant Sanofi and Britain’s GSK announced Thursday the start of final tests of their belated Covid vaccine as

Read more

Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback

A COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them

Read more

Pin It on Pinterest